Details for Patent: 10,322,081

Which drugs does patent 10,322,081 protect, and when does it expire?

Patent 10,322,081 protects ZELSUVMI and is included in one NDA.

This patent has thirteen patent family members in nine countries.

Summary for Patent: 10,322,081

Title:	Topical antiviral compositions and methods of using the same
Abstract:	The present invention relates generally to topical antiviral compositions and methods of using the same.
Inventor(s):	Kimberly McHale, Ryan Doxey, Nathan Stasko
Assignee:	Ligand Pharmaceuticals Inc
Application Number:	US15/324,332
Patent Claim Types: see list of patent claims	Use; Composition;

Drugs Protected by US Patent 10,322,081

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Lnhc	ZELSUVMI	berdazimer sodium	GEL;TOPICAL	217424-001	Jan 5, 2024		RX	Yes	Yes						METHOD OF ADMINISTERING A NITRIC OXIDE RELEASING API IN A COMBINATION TOPICAL COMPOSITION
Lnhc	ZELSUVMI	berdazimer sodium	GEL;TOPICAL	217424-001	Jan 5, 2024		RX	Yes	Yes						METHOD OF TREATING AND/OR PREVENTING VIRAL INFECTION WITH A TOPICAL COMPOSITION INCLUDING A NITRIC OXIDE RELEASING API
Lnhc	ZELSUVMI	berdazimer sodium	GEL;TOPICAL	217424-001	Jan 5, 2024		RX	Yes	Yes						METHOD OF TREATING AND/OR PREVENTING MOLLUSCUM CONTAGIOSUM WITH A TOPICAL COMPOSITION INCLUDING A NITRIC OXIDE RELEASING API
Lnhc	ZELSUVMI	berdazimer sodium	GEL;TOPICAL	217424-001	Jan 5, 2024		RX	Yes	Yes						METHOD OF PREVENTING AND/OR REDUCING APPEARANCE AND/OR SIZE OF MALIGNANT LESION WITH A TOPICAL COMPOSITION INCLUDING A NITRIC OXIDE RELEASING API

International Family Members for US Patent 10,322,081

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2015287674
Brazil	112017000456
Canada	2954061
China	106659675
European Patent Office	3166593